181 related articles for article (PubMed ID: 16996165)
1. Pemetrexed-induced edema of the eyelid.
Kurata T; Tamura K; Okamoto I; Satoh T; Nakagawa K; Fukuoka M
Lung Cancer; 2006 Nov; 54(2):241-2. PubMed ID: 16996165
[TBL] [Abstract][Full Text] [Related]
2. Pemetrexed-induced eyelid edema: incidence and clinical manifestations.
Schallier D; Decoster L; Fontaine C; De Grève J
Anticancer Res; 2010 Dec; 30(12):5185-8. PubMed ID: 21187510
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed-induced eyelid edema in lung cancer.
Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
[TBL] [Abstract][Full Text] [Related]
4. Review of a promising new agent--pemetrexed disodium.
Paz-Ares L; Bezares S; Tabernero JM; Castellanos D; Cortes-Funes H
Cancer; 2003 Apr; 97(8 Suppl):2056-63. PubMed ID: 12673697
[TBL] [Abstract][Full Text] [Related]
5. [Study of use of pemetrexed in non-small cell lung cancer].
Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
[TBL] [Abstract][Full Text] [Related]
6. Pemetrexed-associated urticarial vasculitis.
Lopes G; Vincek V; Raez LE
Lung Cancer; 2006 Feb; 51(2):247-9. PubMed ID: 16360237
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed and maintenance therapy for non-small cell lung cancer.
Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
[No Abstract] [Full Text] [Related]
9. Interstitial pneumonitis after treatment with pemetrexed: a rare event?
Hochstrasser A; Benz G; Joerger M; Templeton A; Brutsche M; Früh M
Chemotherapy; 2012; 58(1):84-8. PubMed ID: 22377772
[TBL] [Abstract][Full Text] [Related]
10. Acute generalized exanthematous pustulosis after pemetrexed, and recurrence after re-introduction.
Bracke A; Van Marck E; Lambert J
Clin Exp Dermatol; 2009 Apr; 34(3):337-9. PubMed ID: 18699838
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed-induced edema of the eyelid.
Guhl G; Diaz-Ley B; Sanchez-Perez J; Jimenez U; Garcia-Diez A
Lung Cancer; 2010 Aug; 69(2):249-50. PubMed ID: 20488577
[No Abstract] [Full Text] [Related]
12. Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Duruisseaux M; Cadranel J; Biron E; Pérol M; Guérin JC; Arpin D
Lung Cancer; 2009 Sep; 65(3):385-7. PubMed ID: 19346028
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed-induced hyperpigmentation of the skin.
Schallier D; Decoster L; de Greve J
Anticancer Res; 2011 May; 31(5):1753-5. PubMed ID: 21617235
[TBL] [Abstract][Full Text] [Related]
14. [Safety of pemetrexed mono-therapy in elderly patients with non-small cell lung cancer].
Konishi A; Kitada N; Nanjo S; Tanaka S; Tomii K; Katakami N; Hashida T
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1507-10. PubMed ID: 23064061
[TBL] [Abstract][Full Text] [Related]
15. Radiation recall dermatitis with pemetrexed.
Hureaux J; Le Guen Y; Tuchais C; Savary L; Urban T
Lung Cancer; 2005 Nov; 50(2):255-8. PubMed ID: 16111784
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
[TBL] [Abstract][Full Text] [Related]
17. [Update of pemetrexed in thoracic oncology].
Brechot JM; Morère JF
Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
[TBL] [Abstract][Full Text] [Related]
18. A case of pemetrexed-induced acute lung injury in non-small cell lung cancer.
Kim HO; Lee SY; Shim JJ; Kang KH; Shin BK
J Thorac Oncol; 2010 Mar; 5(3):401-2. PubMed ID: 20186027
[No Abstract] [Full Text] [Related]
19. Pemetrexed therapy for malignant pleural mesothelioma.
Puto K; Garey JS
Ann Pharmacother; 2005 Apr; 39(4):678-83. PubMed ID: 15755794
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment.
Katsenos S; Psara A; Panagou C
J Oncol Pharm Pract; 2013 Mar; 19(1):93-4. PubMed ID: 22357637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]